Andreia has over 10 years of consulting experience in life sciences, with extensive experience in global market access, commercial competitive intelligence, and in navigating EU and LatAm HTA & payer systems, and P&R strategy across several therapeutic areas. She has led several early-stage asset assessments to support BD&L decisions by clients globally.

Andreia has a BS/MS in Chemical Engineering from the University of Porto, Portugal, and Ph.D. in Chemical and Biochemical Engineering from the University of Maryland.